The wait is finally over. If you’ve been tracking the Defense Health Agency (DHA) and their massive OMNIBUS IV vehicle, you know the “on-ramp” has been the talk of the town for months. Well, grab your calendars and clear your late-spring schedule, because we finally have clarity.
Following a series of updates in early 2026, the government has confirmed that the OMNIBUS IV Small Business On-Ramp solicitation is set to drop in late May 2026.
But this isn’t just another contract update. This is a total game-changer for the 8(a) community. The DHA has officially pivoted, narrowing the eligibility for this on-ramp exclusively to 8(a) Certified Small Businesses. With a $10 billion cumulative ceiling and a performance period that stretches all the way to 2032, this is the kind of vehicle that can define a company’s trajectory for the next decade.
At NVS Strategic Solutions, Inc., we believe in the visionary power of small businesses to transform military medicine. This isn’t just about “winning a contract”; it’s about positioning your firm at the forefront of defense health R&D, translational science, and regulatory innovation. Let’s dive into what changed, why it matters, and how you can win.
The 2026 Pivot: Why May is the Month to Watch
Originally, the OMNIBUS IV on-ramp was expected to be a broad small business play, potentially
open to various socioeconomic categories. However, the DHA’s updated acquisition strategy has
cleared the field: This is now an 8(a) exclusive opportunity.
Why the delay to late May? It all comes down to the recently issued FAR Overhaul guidance for the
DoD, which went into effect on February 1, 2026. The government needed extra time to ensure this
massive solicitation is fully compliant with the new regulatory landscape. This shift actually works in
your favor: it gives you more time to fine-tune your strategy, find the right partners, and get your
ducks in a row.
Opportunity Snapshot: The Facts and Figures
Before we get into the strategy, let’s look at the hard data. This is a massive vehicle with incredible
longevity.
- Opportunity Name: OMNIBUS IV – Small Business On-Ramp
- Agency: Defense Health Agency (DHA) / Defense Health Agency Contracting Activity (DHACA)
- Total Ceiling: $10 Billion (Cumulative)
- Primary NAICS: 541714 – Research and Development in Biotechnology
- Set-Aside: 8(a) Small Business ONLY
- Anticipated Solicitation: Late May 2026
- Performance Period: Through June 2032
- Submission Portal:PIEE (Procurement Integrated Enterprise Environment)
One of the most strategic elements of this award is tied to the FAR Overhaul. Under the new rules, contract holders on this vehicle can rely on their size and status representation at the IDIQ level when
proposing on future task orders. Even if you graduate from the 8(a) program or outgrow your small
business size standards later, being on this vehicle now secures your seat at the table for years to
come.
The Boom in Task Order Activity
If you’re wondering if the volume is actually there, the numbers speak for themselves. Since FY2024,
task order activity on OMNIBUS IV has exploded.
Recent data shows that 94% of all task orders issued on this vehicle have occurred between
FY2024 and 2026. We’re looking at over $600 million in obligations across 51 task orders already.
What’s even more encouraging is that the ordering pool is expanding. It’s no longer just DHACA;
we’re seeing activity from Naval Supply Systems Command and the Uniformed Services University of
the Health Sciences.
The momentum is real, and the government is clearly hungry for the specialized R&D and support
services that 8(a) firms bring to the table.
Breaking Down the 4 Market Segments
The OMNIBUS IV vehicle is divided into four distinct market segments. To win, you need to know ex-
actly where you fit: or where you need a partner to fill the gaps.
1. Research and Development (R&D)
This is the heart of the vehicle. It’s about the direct management and performance of medical R&D
that aligns with DoD priority capability gaps. We’re talking about everything from biosurety and qual-
ity standards to FDA regulatory compliance for research deliverables. If you are a Contract Research
Organization (CRO) or a firm capable of self-directed R&D, this is your lane.
2. R&D Support Services
Every great discovery needs an engine behind it. Segment 2 focuses on the support infrastructure:
administrative support, IT services, logistics, and facilities support. This is a high-volume area that
keeps the research machine running smoothly across both CONUS and OCONUS locations.
3. Regulatory Processes
Navigating the maze of human and animal subject research compliance is no small feat. This segment covers animal use programs, human subjects research protection, and FDA IND applications. It’s a
niche, highly specialized area where expertise is worth its weight in gold.
4. Translational Science Support and Services
This is where the “visionary” part of NVS Strategic Solutions really connects. Segment 4 is all about
moving discoveries from the lab into the hands of the warfighter in the field. It includes evidence-
based solution development, implementation strategies, and evaluation planning.
Strategic Teaming: The Non-8(a) Path
While the prime spots are reserved for 8(a) firms, this is still a massive opportunity for the rest of the
industry. If you aren’t an 8(a) firm, your path onto the vehicle is through strategic teaming.
8(a) primes will be looking for partners who can provide technical coverage across all four market
segments. At NVS, we specialize in bridging these gaps. Whether you are an 8(a) firm looking for a
technical powerhouse as a sub, or a large business/non-8(a) small business looking for the right
prime, our teaming strategy services are designed to build winning coalitions.
How NVS Strategic Solutions Leads You to the Win
Winning a spot on a $10B IDIQ isn’t about luck; it’s about a disciplined, visionary approach to capture
and proposal management. The PIEE submission process alone can be a hurdle for the uninitiated,
and the new FAR Overhaul requirements add a layer of complexity that requires expert navigation.
Here is how NVS Strategic Solutions, Inc. helps you cross the finish line:
1. Strategy & Capture Management
We don’t just “write proposals.” We help you define your place in the market. We’ll analyze your past
performance and align it with the specific DHA market segments where you have the highest proba-
bility of winning. Check out our Capture Management and Business Development services to see how
we position our clients for long-term growth.
2. Teaming Strategy & Partnering
As the on-ramp narrows to 8(a) only, the right team is everything. We help 8(a) firms find the techni-
cal “missing links” and help non-8(a) firms find high-performing primes. We believe that when the
right companies collaborate, the mission wins.
3. Proposal Development & PIEE Compliance
The technical approach for OMNIBUS IV needs to be more than just compliant: it needs to be inspirational. Our team handles the heavy lifting of Proposal Management and Writing, ensuring that every narrative reflects your unique capabilities while meeting the rigorous standards of the DHACA. Plus, we’ll make sure your PIEE submission is flawless.
4. Pricing & Rate Development
In the world of R&D, your numbers have to make sense. We provide Price-to-Win Services to help you develop competitive, market-aligned indirect rates that protect your margins while remaining attractive to the government.
The Mission Ahead
The OMNIBUS IV On-Ramp is more than a contract; it’s an invitation to help shape the future of mili-
tary healthcare. From infectious disease research to joint battlefield healthcare, the work done under
this vehicle will save lives.
If you are an 8(a) firm ready to scale, or a health firm looking to team with one, the time to act is now.
Late May 2026 will be here before you know it.
Are you ready to grow? Let’s make it happen.
Ready to start your OMNIBUS IV strategy? Contact us today to schedule a consultation with our
capture experts. Let’s build the future of defense health together.
For more insights on upcoming opportunities and government contracting trends, be sure to sign up
for our Newsletter and explore our Ready, Set, Grow program.
